|
Poveda-Garcia A, Ruiz E, Moreno MJ, Espanol I, Sanchez-Salinas A, Garcia-Hernandez AM, Blanquer M, Martinez I, Sanchez-Villalobos M, Garcia Garay MC, Salido E, Heredia A, Navarro-Almenzar B, Monserrat J, Sanchez-Salas JA, Martinez-Mellado AJ, Minguela A, Campillo JA, Lopez-Hernandez R, Galian JA, Moraleda JM, Roldan V, Cabanas V. Real-world outcomes of tandem ASCT in newly diagnosed multiple myeloma patients with standard risk features: a single-center analysis. Bone Marrow Transplant. 2024 Nov;59(11):1625-1627. doi: 10.1038/s41409-024-02404-1. Epub 2024 Aug 26. No abstract available. PubMed PMID: 39187602.
AÑO: 2024; IF: 4.5
|
39187602
|
Roldan V, Soler-Espejo E, Marin F. Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved. Thromb Haemost. 2024 Apr;124(4):337-339. doi: 10.1055/s-0043-1775582. Epub 2023 Sep 11. No abstract available. PubMed PMID: 37696302.
AÑO: 2024; IF: 5.0
|
|
Martinez-Montesinos L, Rivera-Caravaca JM, Agewall S, Soler E, Lip GYH, Marin F, Roldan V. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity? Biomed Pharmacother. 2023 Feb;158:114064. doi: 10.1016/j.biopha.2022.114064. Epub 2022 Dec 7. PubMed PMID: 36495662.
AÑO: 2023; IF: 6.9
|
|
Lopez-Galvez R, Rivera-Caravaca JM, Roldan V, Orenes-Pinero E, Esteve-Pastor MA, Lopez-Garcia C, Saura D, Gonzalez J, Lip GYH, Marin F. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making. Am Heart J. 2023 Apr;258:1-16. doi: 10.1016/j.ahj.2022.12.007. Epub 2022 Dec 13. PubMed PMID: 36526006.
AÑO: 2023; IF: 3.7
|
|
Mandaglio-Collados D, Lopez-Galvez R, Ruiz-Alcaraz AJ, Lopez-Garcia C, Roldan V, Lip GYH, Marin F, Rivera-Caravaca JM. Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review. Sci Total Environ. 2023 Jul 1;880:163352. doi: 10.1016/j.scitotenv.2023.163352. Epub 2023 Apr 4. PubMed PMID: 37023806.
AÑO: 2023; IF: 8.2
|